We are live on ! Find out more
EVAX

Evaxion A/S

8 hedge funds and large institutions have $167K invested in Evaxion A/S in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

14,900% more call options, than puts

Call options by funds: $150K | Put options by funds: $1K

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

33% more funds holding

Funds holding: 68 (+2)

0.21% less ownership

Funds ownership: 0.6%0.38% (-0.21%)

56% less capital invested

Capital invested by funds: $377K → $167K (-$210K)

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
1
Closed
2
Calls
$150K
Puts
$1K
Net Calls
+$149K
Net Calls Change
-$1.09M

EVAX Hedge Fund Activity: Q4 2022 in Review

8 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Evaxion A/S (EVAX) for Q4 2022, worth a combined $167K — down 56% from $377K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new EVAX positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Ground Swell Capital, opening a new position worth an estimated $42.3K. The largest seller was Citadel Advisors, cutting an estimated $247K.

  • 8 institutional investors held Evaxion A/S (EVAX) as of Q4 2022, up from 6 in Q3 2022.
  • Funds reported $167K of Evaxion A/S stock for Q4 2022, down 56% quarter-over-quarter.
  • 4 funds opened new Evaxion A/S positions in Q4 2022 and 2 closed out, a net change of +2 holders.
  • The largest Evaxion A/S buyer in Q4 2022 was Ground Swell Capital, an estimated $42.3K added.
  • The largest Evaxion A/S seller in Q4 2022 was Citadel Advisors, an estimated $247K sold.

Based on aggregated 13F filings for Q4 2022.